Ann: Biotron to Test its Compounds Against Coronavirus, page-785

How is everyone? Im back with more cash to buy more BIT after a successful campaign with PDI and DEG. There is some good news recently, researchers from John Hopkins and Harvard said a single drug is not enough, even a fourth and fifth line of antibiotics might be necessary to deal with Sars-Cov-2. Also, the Nature just mentioned yesterday that the demand for Covid19 drugs is massive and the supply will not be enough anytime soon:

"Demand will almost certainly outstrip initial supplies of any compound found to be effective against COVID-19. That raises the spectre of determining who will be first to receive the treatments. Complaints have already surfaced about the allotment of remdesivir: Gilead donated its stocks of the drug to treat COVID-19, with about 40% — enough to treat 78,000 people — going to the United States. The US government has been distributing those vials to individual states, but some hospitals have complained about lack of access."

BIT's shareprice seems to be traders' playground lately. To be honest, Im disappointed at the Board but I cant deny the fact that BIT looks so cheap right now. Hold on tight guys! A picture of me and BIT below. This is not financial advice.